Terms: = Sarcomas AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
144 results:
1. Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.
Ruan GJ; Zanwar S; Ravindran A; Schram S; Abeykoon JP; Hazim A; Young JR; Shah MV; Bennani NN; Jiang L; Morlote D; Rech KL; Goyal G; Go RS;
Am J Hematol; 2024 May; 99(5):871-879. PubMed ID: 38409747
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer.
Rönnlund C; Sifakis EG; Schagerholm C; Yang Q; Karlsson E; Chen X; Foukakis T; Weidler J; Bates M; Fredriksson I; Robertson S; Hartman J
Breast Cancer Res; 2024 Feb; 26(1):24. PubMed ID: 38321542
[TBL] [Abstract] [Full Text] [Related]
3. Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression.
Kitadai R; Nishikawa T; Yoshida H; Mizoguchi C; Yamamoto K; Kato T; Yonemori K
J Gynecol Oncol; 2024 Mar; 35(2):e11. PubMed ID: 37914528
[TBL] [Abstract] [Full Text] [Related]
4. Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study.
Fang X; Zhong C; Weng S; Hu H; Wang J; Xiao Q; Wang J; Sun L; Xu D; Liao X; Dong C; Zhang S; Li J; Ding K; Yuan Y
BMC Cancer; 2023 Jul; 23(1):676. PubMed ID: 37464378
[TBL] [Abstract] [Full Text] [Related]
5. [CIC-rearranged sarcoma: a clinicopathological analysis of four cases].
Wan X; Tang JL; Li X; Wang C; Li H; Pan MH
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):690-695. PubMed ID: 37408399
[No Abstract] [Full Text] [Related]
6. Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and prognosis.
Chiò A; Moglia C; Canosa A; Manera U; Grassano M; Vasta R; Palumbo F; Gallone S; Brunetti M; Barberis M; De Marchi F; Dalgard C; Chia R; Mora G; Iazzolino B; Peotta L; Traynor BJ; Corrado L; D'Alfonso S; Mazzini L; Calvo A
Neurology; 2023 Jul; 101(1):e83-e93. PubMed ID: 37202167
[TBL] [Abstract] [Full Text] [Related]
7. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
[TBL] [Abstract] [Full Text] [Related]
8. Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.
Wang D; Harris J; Kraybill WG; Eisenberg B; Kirsch DG; Ettinger DS; Kane JM; Barry PN; Naghavi A; Freeman CR; Chen YL; Hitchcock YJ; Bedi M; Salerno KE; Severin D; Godette KD; Larrier NA; Curran WJ; Torres-Saavedra PA; Lucas DR
JAMA Oncol; 2023 May; 9(5):646-655. PubMed ID: 36995690
[TBL] [Abstract] [Full Text] [Related]
9. Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Abbou S; Klega K; Tsuji J; Tanhaemami M; Hall D; Barkauskas DA; Krailo MD; Cibulskis C; Nag A; Thorner AR; Pollock S; Imamovic-Tuco A; Shern JF; DuBois SG; Venkatramani R; Hawkins DS; Crompton BD
J Clin Oncol; 2023 May; 41(13):2382-2393. PubMed ID: 36724417
[TBL] [Abstract] [Full Text] [Related]
10. Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib.
de Velasco G; Alonso-Gordoa T; Rodríguez-Vida A; Anguera G; Campayo M; Pinto Á; Ortega EM; Gallardo E; Núñez NF; García-Carbonero I; Reig O; Méndez-Vidal MJ; Fernández-Calvo O; Cassinello NV; Torregrosa D; López-Martín A; Rosero A; Valiente PG; de España CG; Climent MA; Santasusana MD; Sánchez ÁR; González IC; Afonso R; García Del Muro X; Casinello J; Fernández-Parra EM; García Sánchez L; Afonso J; Polo SH; Asensio Ú
Clin Genitourin Cancer; 2023 Jun; 21(3):e166-e174. PubMed ID: 36610891
[TBL] [Abstract] [Full Text] [Related]
11. Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.
Kaptein FHJ; Stals MAM; Evenhuis RE; Gelderblom H; Huisman MV; Karis DSA; Noten RWD; Cannegieter SC; Speetjens FM; Verschoor AJ; Versteeg HH; van de Sande MAJ; Klok FA
Thromb Res; 2023 Jan; 221():19-25. PubMed ID: 36435048
[TBL] [Abstract] [Full Text] [Related]
12. Exome sequencing in a Swedish family with pms2 mutation with varying penetrance of colorectal cancer: investigating the presence of genetic risk modifiers in colorectal cancer risk.
Bryant P; Walton Bernstedt S; Thutkawkorapin J; Backman AS; Lindblom A; Lagerstedt-Robinson K
Eur J Cancer Prev; 2023 Mar; 32(2):113-118. PubMed ID: 36134613
[TBL] [Abstract] [Full Text] [Related]
13. Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Rüschoff JH; Haberecker M; Tsourti Z; Nackaerts K; de Perrot M; Brcic L; Nadal E; Tsimpoukis S; Gray SG; Ampollini L; Aerts JG; Felley-Bosco E; Kirschner MB; Monkhorst K; Weynand B; Bavaghar-Zaeimi F; Samarzija M; Llatjos R; Finn SP; Silini E; von der Thüsen J; Marti N; Vervita K; Kammler R; Peters S; Stahel RA; Baas P; Opitz I;
Mod Pathol; 2022 Dec; 35(12):1888-1899. PubMed ID: 36115922
[TBL] [Abstract] [Full Text] [Related]
14. Feasibility and preliminary efficacy of tantalum components in the management of acetabular reconstruction following periacetabular oncologic resection in primary malignancies.
Zan P; Ma X; Wang H; Cai Z; Shen J; Sun W
Eur J Med Res; 2022 Aug; 27(1):151. PubMed ID: 35978388
[TBL] [Abstract] [Full Text] [Related]
15. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
[TBL] [Abstract] [Full Text] [Related]
16. NTRK -Rearranged Uterine sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
Costigan DC; Nucci MR; Dickson BC; Chang MC; Song S; Sholl LM; Hornick JL; Fletcher CDM; Kolin DL
Am J Surg Pathol; 2022 Oct; 46(10):1415-1429. PubMed ID: 35713627
[TBL] [Abstract] [Full Text] [Related]
17. A Rare Case of A Low-Grade Inflammatory Leiomyosarcoma/Histiocyte-Rich Rhabdomyoblastic Tumor in the Neck of An Adolescent Male.
Rekhi B; Bal M; Dharavath B; Dutt A; Pai P
Turk Patoloji Derg; 2023; 39(2):154-160. PubMed ID: 35642345
[TBL] [Abstract] [Full Text] [Related]
18. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
[TBL] [Abstract] [Full Text] [Related]
19. Histopathological Correlation of Chromosome 12 Polysomy by Fluorescence in Situ Hybridization in Adipocytic Neoplasms.
Wilcock DM; McMurtry V; Coleman JF; Kim JT; Khalili P; Deftereos G; Albertson D; Gulbahce EH; Liu T; Sirohi D
Int J Surg Pathol; 2022 Oct; 30(7):734-742. PubMed ID: 35261272
[No Abstract] [Full Text] [Related]
20. GRWD1-WDR5-MLL2 Epigenetic Complex Mediates H3K4me3 Mark and Is Essential for Kaposi's Sarcoma-Associated Herpesvirus-Induced Cellular Transformation.
Wei S; Lu S; Liang L; Wang X; Li W; Li T; Chen L; Ju E; Zhang X; Lai Z; Huang Y; Lu X; Gao SJ
mBio; 2021 Dec; 12(6):e0343121. PubMed ID: 34933446
[TBL] [Abstract] [Full Text] [Related]
[Next]
